With rapid innovations in biotechnology, companies are developing improved therapies and diagnostic tools addressing rare diseases and improving patient outcomes. Moreover, the use of modern technologies like artificial intelligence (AI) is also transforming the biotech sector.
Amid this backdrop, investors could scoop up shares of fundamentally stable emerging biotech stocks, Veracyte, Inc. (VCYT), Amicus Therapeutics, Inc. (FOLD), and Harmony Biosciences Holdings, Inc. (HRMY) which are pioneering next-gen therapies.
